Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209119
Company: ALEMBIC

Products on ANDA 209119

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209119

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/20/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/08/2021	SUPPL-7	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 209119

CANDESARTAN CILEXETIL

TABLET;ORAL; 32MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ATACAND	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	Yes	AB	020838	ANI PHARMS
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	No	AB	209119	ALEMBIC
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	No	AB	203813	MACLEODS PHARMS LTD
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	No	AB	078702	MYLAN
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	No	AB	206233	PRINSTON INC
CANDESARTAN CILEXETIL	CANDESARTAN CILEXETIL	32MG	TABLET;ORAL	Prescription	No	AB	091390	ZYDUS LIFESCIENCES